7.46
Avadel Pharmaceuticals Plc stock is traded at $7.46, with a volume of 972.19K.
It is down -0.67% in the last 24 hours and down -5.69% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$7.51
Open:
$7.42
24h Volume:
972.19K
Relative Volume:
0.75
Market Cap:
$720.86M
Revenue:
$47.56M
Net Income/Loss:
$-156.83M
P/E Ratio:
-4.0765
EPS:
-1.83
Net Cash Flow:
$-127.98M
1W Performance:
-8.69%
1M Performance:
-5.69%
6M Performance:
-42.88%
1Y Performance:
-54.54%
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Compare AVDL with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AVDL
Avadel Pharmaceuticals Plc
|
7.46 | 720.86M | 47.56M | -156.83M | -127.98M | -1.83 |
![]()
ZTS
Zoetis Inc
|
163.50 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.52B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
UTHR
United Therapeutics Corp
|
312.26 | 13.78B | 2.76B | 1.11B | 898.10M | 22.77 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-11-25 | Initiated | Deutsche Bank | Buy |
Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
Mar-05-24 | Reiterated | Needham | Buy |
Mar-05-24 | Reiterated | Oppenheimer | Outperform |
Feb-06-24 | Initiated | UBS | Buy |
Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
Jul-28-22 | Resumed | Craig Hallum | Buy |
May-26-22 | Downgrade | Stifel | Buy → Hold |
Sep-23-21 | Initiated | Needham | Buy |
Jul-31-20 | Initiated | Oppenheimer | Outperform |
Jul-21-20 | Initiated | SVB Leerink | Outperform |
Jun-30-20 | Initiated | H.C. Wainwright | Buy |
Apr-03-20 | Initiated | Jefferies | Buy |
Mar-12-20 | Initiated | Stifel | Buy |
Feb-26-20 | Initiated | Piper Sandler | Overweight |
Jan-30-20 | Initiated | Craig Hallum | Buy |
Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Teacher Retirement System of Texas Increases Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference - The Manila Times
When (AVDL) Moves Investors should Listen - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Raises Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Swiss National Bank Increases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals Announces Publication of Manuscripts on Narcolepsy Management in CNS Drugs Supplement - Nasdaq
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with Narcolepsy and Their Clinicians - The Manila Times
Avadel Announces Publications in CNS Drugs Supplement Highlighting Key Clinical Issues for People with - EIN News
Atria Investments Inc Has $281,000 Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at UBS Virtual CNS Day: Strategic Growth Insights By Investing.com - Investing.com UK
Bullish Avadel Pharmaceuticals Insiders Loaded Up On US$761.7k Of Stock - simplywall.st
Arizona State Retirement System Acquires 2,938 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals at Leerink Conference: Strategic Growth Plans By Investing.com - Investing.com South Africa
Insider Trading At Avadel Pharmaceuticals plc (NASDAQ: AVDL): What Did We Note? - Stocks Register
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of “Buy” from Analysts - Defense World
Analyzing Avadel Pharmaceuticals plc (AVDL) After Recent Trading Activity - Knox Daily
HC Wainwright Issues Pessimistic Outlook for AVDL Earnings - Defense World
Avadel Pharmaceuticals Announces Executive Equity Grants By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals Announces Executive Equity Grants - Investing.com
Avadel Pharmaceuticals Plc to Host Earnings Call - ACCESS Newswire
Avadel Pharmaceuticals PLC Sponsored ADR to Host Earnings Call - ACCESS Newswire
What is HC Wainwright’s Forecast for AVDL Q3 Earnings? - Defense World
What is Lifesci Capital’s Forecast for AVDL Q2 Earnings? - Defense World
Oppenheimer & Co. Inc. Boosts Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat
Sanctuary Advisors LLC Takes Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Rhumbline Advisers Increases Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
What is Lifesci Capital’s Estimate for AVDL Q1 Earnings? - Defense World
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences - The Manila Times
New York State Common Retirement Fund Sells 389,555 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals (NASDAQ:AVDL) Given “Buy” Rating at HC Wainwright - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2024 Earnings Call Transcript - MSN
Deutsche Bank Adjusts Avadel Pharmaceuticals Price Target to $13 From $12, Maintains Buy Rating - Marketscreener.com
Avadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from Needham & Company LLC - Defense World
Avadel Pharmaceuticals PLC (AVDL) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Avadel Pharmaceuticals Reports Strong Growth in 2024 - TipRanks
Oppenheimer maintains Avadel Outperform rating, $22 target By Investing.com - Investing.com UK
Earnings call transcript: Avadel Pharmaceuticals Q4 2024 reveals revenue miss - Investing.com India
Avadel Pharma earnings missed by $0.03, revenue fell short of estimates - Investing.com Australia
Avadel Pharmaceuticals PLC reports results for the quarter ended December 31Earnings Summary - TradingView
AVADEL PHARMACEUTICALS PLC SEC 10-K Report - TradingView
Avadel: Q4 Earnings Snapshot - CTPost
Avadel Pharmaceuticals Reiterates 2025 Guidance as it Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Avadel Pharmaceuticals Reiterates 2025 Guidance -March 03, 2025 at 07:16 am EST - Marketscreener.com
Is Avadel Pharmaceuticals plc (AVDL) the Best Small Cap Pharma Stocks to Buy Now? - Insider Monkey
Avadel Pharmaceuticals (AVDL) Expected to Announce Earnings on Monday - Defense World
Avadel Pharmaceuticals PLC expected to post a loss of 4 cents a shareEarnings Preview - TradingView
Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2024 Financial Results on March 3 - The Manila Times
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):